|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 36337 |
FusionGeneSummary for STARD13_TNFRSF8 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: STARD13_TNFRSF8 | Fusion gene ID: 36337 | Hgene | Tgene | Gene symbol | STARD13 | TNFRSF8 | Gene ID | 90627 | 943 |
| Gene name | StAR related lipid transfer domain containing 13 | TNF receptor superfamily member 8 | |
| Synonyms | ARHGAP37|DLC2|GT650|LINC00464 | CD30|D1S166E|Ki-1 | |
| Cytomap | 13q13.1-q13.2 | 1p36.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | stAR-related lipid transfer protein 13Rho GTPase activating protein on chromosome 13q12StAR-related lipid transfer (START) domain containing 13deleted in liver cancer 2 proteinlong intergenic non-protein coding RNA 464 | tumor necrosis factor receptor superfamily member 8CD30L receptorKi-1 antigencytokine receptor CD30lymphocyte activation antigen CD30 | |
| Modification date | 20180519 | 20180522 | |
| UniProtAcc | Q9Y3M8 | P28908 | |
| Ensembl transtripts involved in fusion gene | ENST00000336934, ENST00000255486, ENST00000399365, ENST00000487412, ENST00000439831, | ENST00000263932, ENST00000417814, ENST00000413146, ENST00000479933, | |
| Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 3 X 4 X 3=36 |
| # samples | 6 | 3 | |
| ** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/36*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: STARD13 [Title/Abstract] AND TNFRSF8 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | TNFRSF8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 16108830 |
| Tgene | TNFRSF8 | GO:0043065 | positive regulation of apoptotic process | 16108830 |
| Tgene | TNFRSF8 | GO:0045556 | positive regulation of TRAIL biosynthetic process | 16108830 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-BH-A0C7-01B | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000336934 | ENST00000263932 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| Frame-shift | ENST00000336934 | ENST00000417814 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5CDS-intron | ENST00000336934 | ENST00000413146 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5CDS-intron | ENST00000336934 | ENST00000479933 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000255486 | ENST00000263932 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000255486 | ENST00000417814 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000255486 | ENST00000413146 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000255486 | ENST00000479933 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000399365 | ENST00000263932 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000399365 | ENST00000417814 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000399365 | ENST00000413146 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000399365 | ENST00000479933 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5UTR-3CDS | ENST00000487412 | ENST00000263932 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5UTR-3CDS | ENST00000487412 | ENST00000417814 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5UTR-intron | ENST00000487412 | ENST00000413146 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| 5UTR-intron | ENST00000487412 | ENST00000479933 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000439831 | ENST00000263932 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-3CDS | ENST00000439831 | ENST00000417814 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000439831 | ENST00000413146 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
| intron-intron | ENST00000439831 | ENST00000479933 | STARD13 | chr13 | 33859607 | - | TNFRSF8 | chr1 | 12169623 | + |
Top |
FusionProtFeatures for STARD13_TNFRSF8 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| STARD13 | TNFRSF8 |
| Receptor for TNFSF8/CD30L. May play a role in theregulation of cellular growth and transformation of activatedlymphoblasts. Regulates gene expression through activation of NF-kappa-B. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for STARD13_TNFRSF8 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for STARD13_TNFRSF8 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| STARD13 | TUBA1A, KIF1B, HMGCR, EPB41L1, SMARCD3, TAX1BP1, HSP90AA1, ITPR1, BAI2, SMAD1, S100A7, SERPINB4, KCTD3, KIF13B, ZBTB21, KSR1, GIGYF1, CGN, LRFN1, DENND1A, RTKN, SH3PXD2A, MAST3, SRGAP2, EIF4E2, SIPA1L1, PPM1H, LIMA1, MAGI1, TESK2, DCLK1, ZNF638, DENND4C, NF1, HDAC4, CBY1, CDC25C, INPP5E | TNFRSF8 | TNFSF8, TDP2, TRAF5, TRAF2, TRAIP, BCL6, TRAF1, TRAF3, TNFRSF8, NAA25, CCDC112, NAA20, CEP57, DPY19L1, DAPK3, SPATS2, BLOC1S1, EXOC1, ATP6V1D, GOLPH3L, RACGAP1, FHL2, KIF3A, NDC1, CDC6, GOLPH3 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for STARD13_TNFRSF8 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | TNFRSF8 | P28908 | DB08870 | Brentuximab vedotin | Tumor necrosis factor receptor superfamily member 8 {ECO:0000312|HGNC:HGNC:11923} | biotech | approved|investigational |
Top |
RelatedDiseases for STARD13_TNFRSF8 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | STARD13 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | TNFRSF8 | C0019829 | Hodgkin Disease | 2 | CTD_human |
| Tgene | TNFRSF8 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|